|
Elucidating the Regulation and Function of the NF1 tumor suppressor
|
2R01CA111754-11A1
|
$316,635
|
$158,318
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Developmental and HyperActive Ras Tumor SPORE
|
5U54CA196519-02
|
$2,162,000
|
$1,816,080
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ 6) Exploiting Frequent Alterations in the PRC2 Complex to Distinguish Benign Neurofibromas from Malignant Peripheral Nerve Sheath Tumors
|
1R21CA208723-01
|
$212,824
|
$212,824
|
BETTEGOWDA, CHETAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Developing Endpoints to Facilitate Clinical Trials in Rare Diseases
|
1R13CA203289-01
|
$3,993
|
$3,993
|
PLOTKIN, SCOTT
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma
|
1R01CA201130-01A1
|
$400,389
|
$400,389
|
RAMESH, VIJAYA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-42S1
|
$60,000
|
$600
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-42S2
|
$650,997
|
$6,510
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-42S3
|
$750,000
|
$7,500
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-42
|
$5,755,389
|
$57,554
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Molecular Basis of Familial Paraganglioma
|
4R01CA166025-04
|
$296,933
|
$296,933
|
MAHER, LOUIS
|
MAYO CLINIC ROCHESTER
|
|
Phospholipid and Sphingolipid Signaling in Drosophila
|
ZIA BC 010331
|
$210,337
|
$210,337
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$841,347
|
$841,347
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$791,464
|
$39,573
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$202,987
|
$20,299
|
Barr, Frederic
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
$101,493
|
Barr, Frederic
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$280,052
|
$112,021
|
Beutler, John
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$371,569
|
$37,157
|
Bottaro, Donald
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$364,996
|
$109,499
|
Buck, Christopher
|
CCR (NCI)
|
|
Molecular Profiling of Patients Undergoing Radiotherapy
|
ZIA SC 010372
|
$502,992
|
$352,095
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$754,489
|
$603,591
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$5,116,524
|
$818,644
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,732,997
|
$736,650
|
Custer, Mary
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$469,706
|
$70,456
|
Daar, Ira
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$469,706
|
$164,397
|
Daar, Ira
|
CCR (NCI)
|
|
Effects of Cytosine Modifications on Transcription Factor Binding
|
ZIC BC 011724
|
$137,896
|
$137,896
|
Durell, Stewart
|
CCR (NCI)
|
|
Clinical Pharmacogenetics
|
ZIA BC 010627
|
$517,981
|
$25,899
|
Figg, William
|
CCR (NCI)
|
|
Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas
|
ZIA BC 011640
|
$192,561
|
$192,561
|
Gilbert, Mark
|
CCR (NCI)
|
|
Rare Central Nervous System Cancers Initiative
|
ZIA BC 011643
|
$269,586
|
$269,586
|
Gilbert, Mark
|
CCR (NCI)
|
|
Identifying New Glioma-Associated Tumor Suppressors & Oncogenes
|
ZIA BC 011647
|
$269,586
|
$269,586
|
Gilbert, Mark
|
CCR (NCI)
|
|
Brain Tumor Immunotherapy
|
ZIA BC 011714
|
$269,586
|
$269,586
|
Gilbert, Mark
|
CCR (NCI)
|
|
Pre-clinical Translational Research Facility
|
ZIC BC 011641
|
$1,270,905
|
$1,270,905
|
Gilbert, Mark
|
CCR (NCI)
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011642
|
$1,579,003
|
$1,579,003
|
Gilbert, Mark
|
CCR (NCI)
|
|
Pediatric Oncology Branch Behavioral Science Core
|
ZID BC 011517
|
$835,175
|
$835,175
|
Glod, John
|
CCR (NCI)
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 011516
|
$3,340,699
|
$1,336,280
|
Glod, John
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$373,564
|
$67,241
|
Gottesman, Michael
|
CCR (NCI)
|
|
Mechanism, Regulation and Application of miRNA pathway in cancer
|
ZIA BC 011566
|
$829,419
|
$165,884
|
Gu, Shuo
|
CCR (NCI)
|
|
Selenium in Health and its incorporation into Protein as Selenocysteine
|
ZIA BC 011620
|
$193,903
|
$9,695
|
Hatfield, Dolph
|
CCR (NCI)
|
|
Development of new antibody-based cancer therapies
|
ZIA BC 010891
|
$817,629
|
$40,881
|
Ho, Mitchell
|
CCR (NCI)
|
|
Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson
|
ZIA BC 011685
|
$178,853
|
$178,853
|
Jackson, Sadhana
|
CCR (NCI)
|
|
BBB Permeability in Preclinical Models
|
ZIA BC 011686
|
$178,853
|
$178,853
|
Jackson, Sadhana
|
CCR (NCI)
|
|
Characterization of Biological Nanoparticle Subsets
|
ZIA BC 011502
|
$368,356
|
$18,418
|
Jones, Jennifer
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$353,472
|
$70,694
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$353,472
|
$70,694
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Mechanisms of transcription fidelity in prokaryotes and eukaryotes
|
ZIA BC 010795
|
$689,279
|
$344,639
|
Kashlev, Mikhail
|
CCR (NCI)
|
|
Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma
|
ZIA BC 010806
|
$175,638
|
$87,819
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$526,915
|
$237,112
|
Khan, Javed
|
CCR (NCI)
|
|
Bioinformatics: Systems Biology of Pediatric Cancers
|
ZIA BC 011002
|
$351,277
|
$351,277
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
ZIA SC 010366
|
$175,638
|
$87,819
|
Khan, Javed
|
CCR (NCI)
|
|
Postmortem Pathology
|
ZIC BC 010685
|
$530,709
|
$53,071
|
Kleiner, David
|
CCR (NCI)
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,020,805
|
$153,121
|
Kraemer, Kenneth
|
CCR (NCI)
|
Total relevant funding to Nervous System for this search: $29,527,543
|